|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||||||||||
| Cash | ||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||
| Cash and cash equivalents held in trust account | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Non-current assets | ||||||||||||||||||
| Cash and cash equivalents held in Trust Account | ||||||||||||||||||
| Total non-current assets | ||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||
| Current liabilities | ||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||
| Administrative service fee payable - related party | ||||||||||||||||||
| Loan payable - related parties | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total loan payable - related parties | ||||||||||||||||||
| Convertible promissory note payable - related party | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total convertible promissory note payable - related party | ||||||||||||||||||
| Deferred underwriting commission payable | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Non-current liabilities | ||||||||||||||||||
| Loan payable - related party | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total loan payable - related party | ||||||||||||||||||
| Deferred underwriting commission payable | ||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||
| Class A ordinary shares, $0.0001 par value, subject to possible redemption 12,352 shares at redemption value of $13.14 and $13.03 per share, including dividends earned on Trust Account, at March 31, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Class A Ordinary Shares | ||||||||||||||||||
| Total class A ordinary shares, $0.0001 par value, subject to possible redemption 12,352 shares at redemption value of $13.14 and $13.03 per share, including dividends earned on Trust Account, at March 31, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Total commitments and contingencies | ||||||||||||||||||
| SHAREHOLDERS’ DEFICIT | ||||||||||||||||||
| Ordinary shares, Value | ||||||||||||||||||
| Class A Ordinary Shares | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total shareholders’ deficit | ||||||||||||||||||
| TOTAL LIABILITIES, COMMITMENTS AND CONTINGENCIES, AND SHAREHOLDERS’ DEFICIT | ||||||||||||||||||
Loading...
